Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06268951
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
Key Dates
- Start date
- May 9, 2024
- Status verified
- May 2026
- Primary completion
- Feb 29, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Symptom severity due to abdominal wall endometriosis following ablation. [ Time Frame: Baseline and intermittently over 24 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By condition
By specialty
By research site
Related Studies
- Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruiting · Mayo Clinic · Scottsdale, Arizona
- Vaginal Ecosystem and Network in the United States StudyEnrolling By Invitation · Vaginal Biome Science · Fullerton, California
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin